Countdown of Alexion, developer of Soliris, to enter the domestic market
Another global pharmaceutical company is confirmed to consider a market entry to Korea.
The company is Alexion Pharmaceuticals, domestically well-known as a developing company of ‘Soliris, a PNH(paroxysmal nocturnal hemoglobinuria) therapy.
According to the industry concerned on the 25th, the c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
